This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Span-America Reports Growth In Sales And Net Income For Second Quarter Of Fiscal 2012

Span-America Medical Systems, Inc. (NASDAQ:SPAN) today reported strong growth in sales and net income for the second fiscal quarter and six months ended March 31, 2012. Net income for the second quarter of fiscal 2012 rose 74% to $1.8 million, or $0.62 per diluted share, compared with $1.1 million, or $0.37 per diluted share, in the second quarter of fiscal 2011. Net sales for the second quarter of 2012 increased 56% to $20.9 million compared with net sales of $13.5 million in the second quarter of fiscal 2011.

“Span-America’s excellent results came from the acquisition of M.C. Healthcare and solid growth in our custom products segment compared with last year,” stated Jim Ferguson, president and chief executive officer of Span-America Medical Systems. “We are very pleased with our strong sales and earnings performance and believe it demonstrates the growth potential we can achieve with the addition of the M.C. Healthcare business.

“This was the first full quarter of operations for M.C. Healthcare as a part of Span-America, and the new unit contributed approximately $4.9 million in revenue during the quarter. Their excellent performance was partly the result of higher seasonal sales during the quarter as several Canadian provinces increased purchases ahead of their March 31 st fiscal year-ends. We expect the addition of M.C. Healthcare to expand our future sales opportunities by combining Span-America’s proprietary medical therapeutic support surfaces with M.C. Healthcare’s line of medical bed frames. We believe the combination of these products will allow us to be more competitive and expand our product offerings in key market segments,” continued Mr. Ferguson.

Second Quarter Results

Second quarter sales for fiscal 2012 rose 56% to $20.9 million compared with $13.5 million in the second quarter of last year. The majority of the sales growth was due to the newly acquired M.C. Healthcare product lines and higher sales in the custom products segment.

1 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,081.89 -49.97 -0.29%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,796.6090 -42.0340 -0.87%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs